451 related articles for article (PubMed ID: 29782486)
1. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study.
Singh-Manoux A; Fayosse A; Sabia S; Tabak A; Shipley M; Dugravot A; Kivimäki M
PLoS Med; 2018 May; 15(5):e1002571. PubMed ID: 29782486
[TBL] [Abstract][Full Text] [Related]
2. Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study.
Dugravot A; Fayosse A; Dumurgier J; Bouillon K; Rayana TB; Schnitzler A; Kivimaki M; Sabia S; Singh-Manoux A
Lancet Public Health; 2020 Jan; 5(1):e42-e50. PubMed ID: 31837974
[TBL] [Abstract][Full Text] [Related]
3. Role of socioeconomic, lifestyle, and clinical factors in the progression of cardiometabolic multimorbidity in China: A 10-year prospective cohort study.
Li D; Wang L; Zhou Z; Song L; Chen S; Yang Y; Hu Y; Wang Y; Wu S; Tian Y
Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2383-2391. PubMed ID: 35965247
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study.
Freisling H; Viallon V; Lennon H; Bagnardi V; Ricci C; Butterworth AS; Sweeting M; Muller D; Romieu I; Bazelle P; Kvaskoff M; Arveux P; Severi G; Bamia C; Kühn T; Kaaks R; Bergmann M; Boeing H; Tjønneland A; Olsen A; Overvad K; Dahm CC; Menéndez V; Agudo A; Sánchez MJ; Amiano P; Santiuste C; Gurrea AB; Tong TYN; Schmidt JA; Tzoulaki I; Tsilidis KK; Ward H; Palli D; Agnoli C; Tumino R; Ricceri F; Panico S; Picavet HSJ; Bakker M; Monninkhof E; Nilsson P; Manjer J; Rolandsson O; Thysell E; Weiderpass E; Jenab M; Riboli E; Vineis P; Danesh J; Wareham NJ; Gunter MJ; Ferrari P
BMC Med; 2020 Jan; 18(1):5. PubMed ID: 31918762
[TBL] [Abstract][Full Text] [Related]
5. Association of body mass index with risk of cardiometabolic disease, multimorbidity and mortality: a multi-state analysis based on the Kailuan cohort.
Xia X; Chen S; Tian X; Xu Q; Zhang Y; Zhang X; Li J; Wang P; Wu S; Wang A
Endocrine; 2024 May; 84(2):355-364. PubMed ID: 37878230
[TBL] [Abstract][Full Text] [Related]
6. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe.
Kivimäki M; Kuosma E; Ferrie JE; Luukkonen R; Nyberg ST; Alfredsson L; Batty GD; Brunner EJ; Fransson E; Goldberg M; Knutsson A; Koskenvuo M; Nordin M; Oksanen T; Pentti J; Rugulies R; Shipley MJ; Singh-Manoux A; Steptoe A; Suominen SB; Theorell T; Vahtera J; Virtanen M; Westerholm P; Westerlund H; Zins M; Hamer M; Bell JA; Tabak AG; Jokela M
Lancet Public Health; 2017 Jun; 2(6):e277-e285. PubMed ID: 28626830
[TBL] [Abstract][Full Text] [Related]
7. Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study.
Kivimäki M; Pentti J; Ferrie JE; Batty GD; Nyberg ST; Jokela M; Virtanen M; Alfredsson L; Dragano N; Fransson EI; Goldberg M; Knutsson A; Koskenvuo M; Koskinen A; Kouvonen A; Luukkonen R; Oksanen T; Rugulies R; Siegrist J; Singh-Manoux A; Suominen S; Theorell T; Väänänen A; Vahtera J; Westerholm PJM; Westerlund H; Zins M; Strandberg T; Steptoe A; Deanfield J;
Lancet Diabetes Endocrinol; 2018 Sep; 6(9):705-713. PubMed ID: 29884468
[TBL] [Abstract][Full Text] [Related]
8. Role of depression in the development of cardiometabolic multimorbidity: Findings from the UK Biobank study.
Qiao Y; Ding Y; Li G; Lu Y; Li S; Ke C
J Affect Disord; 2022 Dec; 319():260-266. PubMed ID: 36162655
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Physical Activity Intensity on the Dynamic Progression of Cardiometabolic Multimorbidity: Prospective Cohort Study Using UK Biobank Data.
Liu BP; Zhu JH; Wan LP; Zhao ZY; Wang X; Jia CX
JMIR Public Health Surveill; 2023 Sep; 9():e46991. PubMed ID: 37747776
[TBL] [Abstract][Full Text] [Related]
10. Associations between consumption of three types of beverages and risk of cardiometabolic multimorbidity in UK Biobank participants: a prospective cohort study.
Luo Y; He L; Ma T; Li J; Bai Y; Cheng X; Zhang G
BMC Med; 2022 Aug; 20(1):273. PubMed ID: 35978398
[TBL] [Abstract][Full Text] [Related]
11. Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China.
Zhang H; Duan X; Rong P; Dang Y; Yan M; Zhao Y; Chen F; Zhou J; Chen Y; Wang D; Pei L
Front Cardiovasc Med; 2022; 9():966217. PubMed ID: 36158847
[TBL] [Abstract][Full Text] [Related]
12. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study.
Chudasama YV; Khunti K; Gillies CL; Dhalwani NN; Davies MJ; Yates T; Zaccardi F
PLoS Med; 2020 Sep; 17(9):e1003332. PubMed ID: 32960883
[TBL] [Abstract][Full Text] [Related]
13. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study.
Zhang D; Tang X; Shen P; Si Y; Liu X; Xu Z; Wu J; Zhang J; Lu P; Lin H; Gao P
BMJ Open; 2019 Mar; 9(3):e024476. PubMed ID: 30833320
[TBL] [Abstract][Full Text] [Related]
14. Association between healthy lifestyle and the occurrence of cardiometabolic multimorbidity in hypertensive patients: a prospective cohort study of UK Biobank.
Xie H; Li J; Zhu X; Li J; Yin J; Ma T; Luo Y; He L; Bai Y; Zhang G; Cheng X; Li C
Cardiovasc Diabetol; 2022 Oct; 21(1):199. PubMed ID: 36183084
[TBL] [Abstract][Full Text] [Related]
15. Multimorbidity of cardiometabolic diseases: a cross-sectional study of patterns, clusters and associated risk factors in sub-Saharan Africa.
Otieno P; Asiki G; Wekesah F; Wilunda C; Sanya RE; Wami W; Agyemang C
BMJ Open; 2023 Feb; 13(2):e064275. PubMed ID: 36759029
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic differences in cardiometabolic factors: social causation or health-related selection? Evidence from the Whitehall II Cohort Study, 1991-2004.
Elovainio M; Ferrie JE; Singh-Manoux A; Shipley M; Batty GD; Head J; Hamer M; Jokela M; Virtanen M; Brunner E; Marmot MG; Kivimäki M
Am J Epidemiol; 2011 Oct; 174(7):779-89. PubMed ID: 21813793
[TBL] [Abstract][Full Text] [Related]
17. Associations of Cardiometabolic Multimorbidity With All-Cause and Coronary Heart Disease Mortality Among Black Adults in the Jackson Heart Study.
Joseph JJ; Rajwani A; Roper D; Zhao S; Kline D; Odei J; Brock G; Echouffo-Tcheugui JB; Kalyani RR; Bertoni AG; Effoe VS; Sims M; Wu WC; Wand GS; Golden SH
JAMA Netw Open; 2022 Oct; 5(10):e2238361. PubMed ID: 36282500
[TBL] [Abstract][Full Text] [Related]
18. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.
Jani BD; Hanlon P; Nicholl BI; McQueenie R; Gallacher KI; Lee D; Mair FS
BMC Med; 2019 Apr; 17(1):74. PubMed ID: 30967141
[TBL] [Abstract][Full Text] [Related]
19. The association between sleep characteristics and the risk of all-cause mortality among individuals with cardiometabolic multimorbidity: a prospective study of UK Biobank.
He L; Ma T; Cheng X; Bai Y
J Clin Sleep Med; 2023 Apr; 19(4):651-658. PubMed ID: 36644852
[TBL] [Abstract][Full Text] [Related]
20. Cardiometabolic multimorbidity, lifestyle behaviours, and cognitive function: a multicohort study.
Jin Y; Liang J; Hong C; Liang R; Luo Y
Lancet Healthy Longev; 2023 Jun; 4(6):e265-e273. PubMed ID: 37150183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
